共 50 条
- [42] Sulforaphane ameliorates non-alcoholic fatty liver disease in mice by promoting FGF21/FGFR1 signaling pathway ACTA PHARMACOLOGICA SINICA, 2022, 43 (06): : 1473 - 1483
- [43] Sulforaphane ameliorates non-alcoholic fatty liver disease in mice by promoting FGF21/FGFR1 signaling pathway Acta Pharmacologica Sinica, 2022, 43 : 1473 - 1483
- [48] Therapeutic effects of Spirulina against experimentally-induced non-alcoholic fatty liver in rats may involve miR-21, -34a and -122 META GENE, 2018, 18 : 115 - 121